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Over the past twenty years, the international landscape for
health programming in developing countries has changed
dramatically, and global awareness of the consequences of
poor health has grown. One result is the international
commitment to the Millennium Development Goals
(MDGs) that has put poverty reduction and health at the
forefront of the global agenda. And, as new funding agen-
cies and mechanisms (e.g., GFATM, GAVI, PEPFAR,
PMI) appeared, attention focused more closely on the
impact of their expenditures. Major donors - multilateral,
bilateral and private - have embraced ‘results-based pro-
gramming’. They ask whether they are getting ‘value for
money’. And the commitment of national leaders to the
MDGs confirms that they, as well as the donors, expect
accountability for the significant expenditures now being
made on health programs. Ultimately, what the global
health community wants to know is which programs of
service delivery can most efficiently improve health.
Without strong evaluations designed to measure impact,
decision-makers lack sufficient evidence to fund expansion
of service delivery or behavior change programs, and
doing so without data on impact might even be considered
unethical [1]. But there are many constraints to measuring
the impact of large, complex programs, and studies to
evaluate impact are expensive and take time [2].
The global health community has instead relied almost
exclusively on measurements of intervention coverage,
behaviors, and levels of mortality and fertility from house-
hold surveys to assess progress. This approach has a long
tradition, starting in the 1970s with the World Fertility
and Contraceptive Prevalence Surveys, and continues
today with the Demographic and Health Surveys and the
Multiple Indicator Cluster Surveys, which are the main
vehicle for measuring progress toward many of the
MDGs. But from the point of implementing organizations,
surveys do not provide timely information, and rarely
report below regional or provincial level, when more
specific data are often needed for program management.
Surveys are also expensive and they leave a large gap - a
black box - between program inputs and their outcomes
and impact. Many implementing organizations are looking
for new approaches to express the impact, equity and
breadth of their programs.
The papers in this Supplement provide a middle ground
solution. They give us the opportunity to examine how
two organizations that implement global health programs
are addressing the need to assess performance, make stra-
tegic decisions about their programmatic priorities based
on performance and goals, and at the same time be
accountable to funders and national stakeholders. The
papers provide details about how these program imple-
menters are translating routinely-collected data on pro-
gram outputs - either commodities distributed or services
provided - into estimates of impact on health status, as
expressed in disability-adjusted life years (DALYs) averted
and on outcomes as expressed in changes in contraceptive
prevalence and contribution to national indicators. The
papers describe a range of organizational uses for data on
impact, as well as analytic methods for examining equity
in health status and program exposure that may be used
to guide program development.
The supplement was stimulated by the growing interest
in finding a set of common metrics that can be used at
both the programmatic and global level for making deci-
sions and setting priorities for action. As more organiza-
tions look to adopt such metrics, there is an increasing
need for a published evidence base that can be used to
inform and align measurement. After substantial invest-
ments in its own measurement program and at the request
of other agencies wishing to adopt some of its core
metrics, PSI worked with a group of partners and stake-
holders to produce this supplement. The authors invite
review of these metrics and their applications, hoping that
the papers will engage the implementing community in
debates on metrics that until now have largely been the
purview of the academic community.Correspondence: pdavid@pathfinder.org
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Thus, the supplement has several purposes. First, to
share information on various models that can be used
to translate outputs into impact estimates. Second, to
provide some examples of how implementing organiza-
tions have applied these metrics for a variety of pur-
poses. The papers included here identify some of the
benefits of the current models as well as their limita-
tions, and expose measurement gaps that remain.
Finally, the papers identify some of the challenges for
implementing organizations posed by the requirements
of the models. The Commentaries that follow also high-
light some of the challenges that face the global health
community in our quest for data to inform program and
policy decisions.
The first paper in the series, by Longfield and collea-
gues [3], describes the application of the DALYs averted
metric to assess performance across PSI’s global portfo-
lio, describing its use to improve the organization’s stra-
tegic decisions. This illustration is followed by a paper
by Yang and colleagues [4] that provides the details of
the DALYs averted models: a description of the struc-
ture, assumptions and model parameters and data inputs
for two types of DALYs averted models. Two worked
examples using PSI data are also provided, with an
extended discussion of the challenges of customizing
and updating the models, as well as limitations and
plans for future improvements.
Next, the paper by Montagu and colleagues illustrates
the utility of the DALYs averted metric for making com-
parisons among programs, as well as assessing program
growth and impact using data from a large number of
social franchise programs that deliver a variety of ser-
vices and are managed by many different implementing
organizations [5]. The paper makes the case that despite
challenges in quality of data currently reported by some
programs, DALYs averted are a promising opportunity
to promote data sharing and transparency among the
social franchise community.
The final papers by Weinberger and colleagues [6] and
Chakraborty and colleagues [7] describe two other
approaches. In the first, Weinberger describes how Marie
Stopes International (MSI)’s Impact 2 model converts data
on contraceptive service provision into estimates of num-
bers of family planning users, and, while allowing for fac-
tors such as population growth and a number of other
adjustments, estimates the attributable contribution of the
organization to national levels of contraceptive prevalence
without recourse to surveys. In the final paper, Chakra-
borty and colleagues demonstrate how a combination of
analytic methods for assessing equity in health behavior
outcomes and intervention exposures - the concentration
index and wealth quintiles - is useful for programmatic
decision making. Employing characteristics of both meth-
ods, social marketers and other implementers can monitor
the equity of their programs and improve targeting when
the poor are not being reached.
For many organizations with limited resources, there is a
tension between the need to be accountable to donors, to
efficiently use funds for programmatic activities, and to
learn what works best. The work described in the papers
that follow required considerable investment in modeling
expertise, as well as in collecting comparable data from
multiple countries and projects. Many organizations that
implement very disparate health programs on a smaller
scale may find the data requirements for these models
daunting. And moving from service outputs to health
impact omits several layers of important information that
is also needed for managing performance and learning
from program results. The need for effectiveness evalua-
tions, as well as for more complex impact evaluations, will
not diminish.
The organizational uses of the methods and models
described here for - program planning, for strategy devel-
opment, for advocacy - and the opportunity to promote
collaboration across organizations through use of standar-
dized metrics are promising. The potential to gain a better
understanding of whether health programs are well-posi-
tioned to meet their ultimate goal of improving health is
definitely worth exploring.
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